CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $36,000 | -96.8% | 6,500 | -97.0% | 0.00% | – |
| Q1 2021 | $1,141,000 | +5333.3% | 217,290 | +3521.5% | 0.00% | – |
| Q4 2020 | $21,000 | +75.0% | 6,000 | -2.4% | 0.00% | – |
| Q3 2020 | $12,000 | – | 6,147 | +6047.0% | 0.00% | – |
| Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 100 | +100.0% | 0.00% | – |
| Q4 2017 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 50 | -50.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 100 | -95.2% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,100 | +68.0% | 0.00% | – |
| Q3 2016 | $2,000 | -50.0% | 1,250 | -0.4% | 0.00% | – |
| Q2 2016 | $4,000 | +300.0% | 1,255 | +358.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 274 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -97.8% | 274 | -97.4% | 0.00% | – |
| Q3 2015 | $45,000 | -29.7% | 10,443 | -29.3% | 0.00% | – |
| Q2 2015 | $64,000 | +3100.0% | 14,773 | +3146.8% | 0.00% | – |
| Q1 2015 | $2,000 | – | 455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
| Renaissance Technologies | 165,651 | $571,000 | 0.00% |
| VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
| UBS Group AG | 4,812 | $17,000 | 0.00% |
| IFP Advisors, Inc | 150 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |